Engineered botulinum neurotoxin B with improved efficacy for targeting human receptors

Humans are less sensitive to the therapeutic effects of botulinum neurotoxin B (BoNT/B) than the animal models it is tested on due to differences between the human and the mouse receptors. Here, the authors engineer BoNT/B to improve its affinity to human receptors and enhance its therapeutic effica...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Liang Tao, Lisheng Peng, Ronnie P.-A. Berntsson, Sai Man Liu, SunHyun Park, Feifan Yu, Christopher Boone, Shilpa Palan, Matthew Beard, Pierre-Etienne Chabrier, Pål Stenmark, Johannes Krupp, Min Dong
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
Q
Acceso en línea:https://doaj.org/article/c4a98be4d71a49939f118b13ff4c9b03
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c4a98be4d71a49939f118b13ff4c9b03
record_format dspace
spelling oai:doaj.org-article:c4a98be4d71a49939f118b13ff4c9b032021-12-02T13:27:30ZEngineered botulinum neurotoxin B with improved efficacy for targeting human receptors10.1038/s41467-017-00064-y2041-1723https://doaj.org/article/c4a98be4d71a49939f118b13ff4c9b032017-07-01T00:00:00Zhttps://doi.org/10.1038/s41467-017-00064-yhttps://doaj.org/toc/2041-1723Humans are less sensitive to the therapeutic effects of botulinum neurotoxin B (BoNT/B) than the animal models it is tested on due to differences between the human and the mouse receptors. Here, the authors engineer BoNT/B to improve its affinity to human receptors and enhance its therapeutic efficacy.Liang TaoLisheng PengRonnie P.-A. BerntssonSai Man LiuSunHyun ParkFeifan YuChristopher BooneShilpa PalanMatthew BeardPierre-Etienne ChabrierPål StenmarkJohannes KruppMin DongNature PortfolioarticleScienceQENNature Communications, Vol 8, Iss 1, Pp 1-10 (2017)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Liang Tao
Lisheng Peng
Ronnie P.-A. Berntsson
Sai Man Liu
SunHyun Park
Feifan Yu
Christopher Boone
Shilpa Palan
Matthew Beard
Pierre-Etienne Chabrier
Pål Stenmark
Johannes Krupp
Min Dong
Engineered botulinum neurotoxin B with improved efficacy for targeting human receptors
description Humans are less sensitive to the therapeutic effects of botulinum neurotoxin B (BoNT/B) than the animal models it is tested on due to differences between the human and the mouse receptors. Here, the authors engineer BoNT/B to improve its affinity to human receptors and enhance its therapeutic efficacy.
format article
author Liang Tao
Lisheng Peng
Ronnie P.-A. Berntsson
Sai Man Liu
SunHyun Park
Feifan Yu
Christopher Boone
Shilpa Palan
Matthew Beard
Pierre-Etienne Chabrier
Pål Stenmark
Johannes Krupp
Min Dong
author_facet Liang Tao
Lisheng Peng
Ronnie P.-A. Berntsson
Sai Man Liu
SunHyun Park
Feifan Yu
Christopher Boone
Shilpa Palan
Matthew Beard
Pierre-Etienne Chabrier
Pål Stenmark
Johannes Krupp
Min Dong
author_sort Liang Tao
title Engineered botulinum neurotoxin B with improved efficacy for targeting human receptors
title_short Engineered botulinum neurotoxin B with improved efficacy for targeting human receptors
title_full Engineered botulinum neurotoxin B with improved efficacy for targeting human receptors
title_fullStr Engineered botulinum neurotoxin B with improved efficacy for targeting human receptors
title_full_unstemmed Engineered botulinum neurotoxin B with improved efficacy for targeting human receptors
title_sort engineered botulinum neurotoxin b with improved efficacy for targeting human receptors
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/c4a98be4d71a49939f118b13ff4c9b03
work_keys_str_mv AT liangtao engineeredbotulinumneurotoxinbwithimprovedefficacyfortargetinghumanreceptors
AT lishengpeng engineeredbotulinumneurotoxinbwithimprovedefficacyfortargetinghumanreceptors
AT ronniepaberntsson engineeredbotulinumneurotoxinbwithimprovedefficacyfortargetinghumanreceptors
AT saimanliu engineeredbotulinumneurotoxinbwithimprovedefficacyfortargetinghumanreceptors
AT sunhyunpark engineeredbotulinumneurotoxinbwithimprovedefficacyfortargetinghumanreceptors
AT feifanyu engineeredbotulinumneurotoxinbwithimprovedefficacyfortargetinghumanreceptors
AT christopherboone engineeredbotulinumneurotoxinbwithimprovedefficacyfortargetinghumanreceptors
AT shilpapalan engineeredbotulinumneurotoxinbwithimprovedefficacyfortargetinghumanreceptors
AT matthewbeard engineeredbotulinumneurotoxinbwithimprovedefficacyfortargetinghumanreceptors
AT pierreetiennechabrier engineeredbotulinumneurotoxinbwithimprovedefficacyfortargetinghumanreceptors
AT palstenmark engineeredbotulinumneurotoxinbwithimprovedefficacyfortargetinghumanreceptors
AT johanneskrupp engineeredbotulinumneurotoxinbwithimprovedefficacyfortargetinghumanreceptors
AT mindong engineeredbotulinumneurotoxinbwithimprovedefficacyfortargetinghumanreceptors
_version_ 1718393000623603712